Found: 8
Select item for more details and to access through your institution.
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 666, doi. 10.1111/bjh.15080
- By:
- Publication type:
- Article
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 2, p. 73, doi. 10.1034/j.1600-0609.2003.00093.x
- By:
- Publication type:
- Article
Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma.
- Published in:
- Histopathology, 2015, v. 67, n. 1, p. 62, doi. 10.1111/his.12624
- By:
- Publication type:
- Article
Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 1994, v. 53, n. 4, p. 218, doi. 10.1111/j.1600-0609.1994.tb00192.x
- By:
- Publication type:
- Article
B-cell chronic lymphocytic leukaemia: Clonal chromosome abnormalities and prognosis in 89 cases.
- Published in:
- European Journal of Haematology, 1989, v. 43, n. 5, p. 397, doi. 10.1111/j.1600-0609.1989.tb00326.x
- By:
- Publication type:
- Article
Lack of prognostic significance of T-lymphocyte subset counts in B-cell chronic lyrnphocytic leukaemia.
- Published in:
- European Journal of Haematology, 1987, v. 38, n. 1, p. 67, doi. 10.1111/j.1600-0609.1987.tb01427.x
- By:
- Publication type:
- Article
Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 815, doi. 10.1111/bjh.12006
- By:
- Publication type:
- Article
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 3, p. 355, doi. 10.1111/j.1365-2141.2012.09174.x
- By:
- Publication type:
- Article